Dr. Thomas W. Flaig
Claim this profileUniversity of Colorado Hospital
Studies Cancer
Studies Thyroid Cancer
5 reported clinical trials
6 drugs studied
Area of expertise
1Cancer
2Thyroid Cancer
Stage IV
Stage III
FGFR3 positive
Affiliated Hospitals
Clinical Trials Thomas W. Flaig is currently running
Metformin
for Prostate Cancer Patients with Glucose Intolerance or Overweight
Metformin is used widely in the treatment of type 2 diabetes. It has off-label indications for use in the prevention of diabetes and in hyperinsulinar obesity. In medical practices, the implementation of metformin for these off-label indications is variable, often at the level of the provider. Multiple retrospective investigations have also shown a clinical benefit in men with prostate cancer who are incidentally treated with metformin. This pragmatic study will test the feasibility of enrolling patients who have glucose intolerance (as defined by HbA1c of 5.7-6.4%) and/or who have increased BMI (BMI greater than or equal to 25 kg/m2) to a randomized pragmatic study of metformin plus lifestyle modification information versus lifestyle modification information only. For purposes of the scope of this project and the study's feasibility, this will be implemented in a group of prostate cancer patients, who may have additional benefits from metformin.
Recruiting0 awards Phase < 14 criteria
ATG-101
for Advanced Cancers
This trial is testing a new drug called ATG-101 on patients with advanced cancers to see if it can help treat their condition.
Recruiting1 award Phase 15 criteria
More about Thomas W. Flaig
Clinical Trial Related2 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Thomas W. Flaig has experience with
- Metformin
- Nivolumab
- Olaparib
- Enfortumab Vedotin
- Erdafitinib
- ATG-101
Breakdown of trials Thomas W. Flaig has run
Impaired Glucose Tolerance
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Thomas W. Flaig specialize in?
Thomas W. Flaig focuses on Cancer and Thyroid Cancer. In particular, much of their work with Cancer has involved treating patients, or patients who are undergoing treatment.
Is Thomas W. Flaig currently recruiting for clinical trials?
Yes, Thomas W. Flaig is currently recruiting for 5 clinical trials in Aurora Colorado. If you're interested in participating, you should apply.
Are there any treatments that Thomas W. Flaig has studied deeply?
Yes, Thomas W. Flaig has studied treatments such as Metformin, Nivolumab, Olaparib.
What is the best way to schedule an appointment with Thomas W. Flaig?
Apply for one of the trials that Thomas W. Flaig is conducting.
What is the office address of Thomas W. Flaig?
The office of Thomas W. Flaig is located at: University of Colorado Hospital, Aurora, Colorado 80045 United States. This is the address for their practice at the University of Colorado Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.